SONOMA PHARMACEUTICALS, INC. Operating Lease Cost
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Operating Lease Cost of $104.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-08-06
- SONOMA PHARMACEUTICALS, INC. operating lease, cost for the quarter ending 2026-06-30 was $104.00K, a 19.54% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. operating lease, cost for the quarter ending 2026-03-31 was $103.00K, a 17.05% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. operating lease, cost for the quarter ending 2025-12-31 was $98.00K, a 7.69% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. operating lease, cost for the quarter ending 2025-09-30 was $100.00K, a 7.53% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. operating lease, cost for fiscal 2026 was $388.00K, a 6.30% increase from fiscal 2025.
- SONOMA PHARMACEUTICALS, INC. operating lease, cost for fiscal 2025 was $365.00K, a 3.95% decline from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. operating lease, cost for fiscal 2024 was $380.00K, a 1.30% decline from fiscal 2023.
- SONOMA PHARMACEUTICALS, INC. operating lease, cost for fiscal 2023 was $385.00K, a 4.90% increase from fiscal 2022.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $104.00K 10-Q · filed 2026-08-06 | $207.00K derived: sum of 2 quarters · filed 2026-08-06 | $305.00K derived: sum of 3 quarters · filed 2026-08-06 | $405.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $201.00K derived: sum of 2 quarters · filed 2026-06-16 | $301.00K derived: sum of 3 quarters · filed 2026-06-16 | $388.00K 10-K · filed 2026-06-16 |
| 2025-12-31 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | $198.00K derived: sum of 2 quarters · filed 2026-02-10 | $285.00K 10-Q · filed 2026-02-10 | $373.00K derived: sum of 4 quarters · filed 2026-06-16 |
| 2025-09-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-04 | $187.00K 10-Q · filed 2025-11-04 | $275.00K derived: sum of 3 quarters · filed 2026-06-16 | $366.00K derived: sum of 4 quarters · filed 2026-06-16 |
| 2025-06-30 | $87.00K 10-Q · filed 2025-08-07 | $175.00K derived: sum of 2 quarters · filed 2026-06-16 | $266.00K derived: sum of 3 quarters · filed 2026-06-16 | $359.00K derived: sum of 4 quarters · filed 2026-06-16 |
| 2025-03-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $179.00K derived: sum of 2 quarters · filed 2026-06-16 | $272.00K derived: sum of 3 quarters · filed 2026-06-16 | $365.00K 10-K · filed 2026-06-16 |
| 2024-12-31 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-05 | $184.00K derived: sum of 2 quarters · filed 2025-02-05 | $277.00K 10-Q · filed 2025-02-05 | $329.00K derived: sum of 4 quarters · filed 2025-06-17 |
| 2024-09-30 | $93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $186.00K 10-Q · filed 2024-11-07 | $238.00K derived: sum of 3 quarters · filed 2025-06-17 | $350.00K derived: sum of 4 quarters · filed 2025-06-17 |
| 2024-06-30 | $93.00K 10-Q · filed 2024-08-08 | $145.00K derived: sum of 2 quarters · filed 2025-06-17 | $257.00K derived: sum of 3 quarters · filed 2025-06-17 | $370.00K derived: sum of 4 quarters · filed 2025-06-17 |
| 2024-03-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | $164.00K derived: sum of 2 quarters · filed 2025-06-17 | $277.00K derived: sum of 3 quarters · filed 2025-06-17 | $380.00K 10-K · filed 2025-06-17 |
| 2023-12-31 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $225.00K derived: sum of 2 quarters · filed 2024-02-08 | $328.00K 10-Q · filed 2024-02-08 | $434.00K derived: sum of 4 quarters · filed 2024-06-17 |
| 2023-09-30 | $113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | $216.00K 10-Q · filed 2023-11-13 | $322.00K derived: sum of 3 quarters · filed 2024-06-17 | $413.00K derived: sum of 4 quarters · filed 2024-06-17 |
| 2023-06-30 | $103.00K 10-Q · filed 2023-08-10 | $209.00K derived: sum of 2 quarters · filed 2024-06-17 | $300.00K derived: sum of 3 quarters · filed 2024-06-17 | $394.00K derived: sum of 4 quarters · filed 2024-06-17 |
| 2023-03-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-17 | $197.00K derived: sum of 2 quarters · filed 2024-06-17 | $291.00K derived: sum of 3 quarters · filed 2024-06-17 | $385.00K 10-K · filed 2024-06-17 |
| 2022-12-31 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | $185.00K derived: sum of 2 quarters · filed 2023-02-14 | $279.00K 10-Q · filed 2023-02-14 | $372.00K derived: sum of 4 quarters · filed 2023-06-21 |
| 2022-09-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-14 | $188.00K 10-Q · filed 2022-11-14 | $281.00K derived: sum of 3 quarters · filed 2023-06-21 | $370.00K derived: sum of 4 quarters · filed 2023-06-21 |
| 2022-06-30 | $94.00K 10-Q · filed 2022-08-11 | $187.00K derived: sum of 2 quarters · filed 2023-06-21 | $276.00K derived: sum of 3 quarters · filed 2023-06-21 | $367.00K derived: sum of 4 quarters · filed 2023-06-21 |
| 2022-03-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | $182.00K derived: sum of 2 quarters · filed 2023-06-21 | $273.00K derived: sum of 3 quarters · filed 2023-06-21 | $367.00K 10-K · filed 2023-06-21 |
| 2021-12-31 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-11 | $180.00K derived: sum of 2 quarters · filed 2022-02-11 | $274.00K 10-Q · filed 2022-02-11 | $479.00K derived: sum of 4 quarters · filed 2022-07-13 |
| 2021-09-30 | $91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-15 | $185.00K 10-Q · filed 2021-11-15 | $390.00K derived: sum of 3 quarters · filed 2022-07-13 | $451.00K derived: sum of 4 quarters · filed 2022-07-13 |
| 2021-06-30 | $94.00K 10-Q · filed 2021-08-16 | $299.00K derived: sum of 2 quarters · filed 2022-07-13 | $360.00K derived: sum of 3 quarters · filed 2022-07-13 | $481.00K derived: sum of 4 quarters · filed 2022-07-13 |
| 2021-03-31 | $205.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-13 | $266.00K derived: sum of 2 quarters · filed 2022-07-13 | $387.00K derived: sum of 3 quarters · filed 2022-07-13 | $435.00K 10-K · filed 2022-07-13 |
| 2020-12-31 | $61.00K 10-Q · filed 2021-02-16 | $182.00K derived: sum of 2 quarters · filed 2021-02-16 | $230.00K 10-Q · filed 2021-02-16 | $448.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2020-09-30 | $121.00K 10-Q · filed 2020-11-20 | $286.00K 10-Q · filed 2020-11-20 | $387.00K derived: sum of 3 quarters · filed 2020-11-20 | $533.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2020-06-30 | $49.00K 10-Q/A · filed 2020-11-17 | $266.00K derived: sum of 2 quarters · filed 2020-11-17 | $412.00K derived: sum of 3 quarters · filed 2021-02-16 | $560.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2020-03-31 | $217.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-07-10 | $363.00K derived: sum of 2 quarters · filed 2021-02-16 | $511.00K derived: sum of 3 quarters · filed 2021-02-16 | $661.00K 10-K · filed 2020-07-10 |
| 2019-12-31 | $146.00K 10-Q · filed 2021-02-16 | $294.00K derived: sum of 2 quarters · filed 2021-02-16 | $444.00K 10-Q · filed 2021-02-16 | |
| 2019-09-30 | $148.00K 10-Q · filed 2020-11-20 | $298.00K 10-Q · filed 2020-11-20 | ||
| 2019-06-30 | $150.00K 10-Q · filed 2019-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |